Sheryl L. Conley net worth and biography

Sheryl Conley Biography and Net Worth

Director of Neuronetics

Sheryl Conley brings more than 30 years of leadership experience in the medical device industry. Ms. Conley previously served as the Group President – Americas, Global Brand Management and Chief Marketing Officer at Zimmer Holdings, where she led the company’s largest and most profitable business segments. During her 25-year career at Zimmer, she held a number of escalating management roles across a variety of product segments and geographies, during which she provided key leadership in the development and commercial release of over 50 industry leading brands. She holds a Bachelor of Science in Biology and Chemistry and an MBA from Ball State University in Indiana. Ms. Conley is a member of the Audit committee.

What is Sheryl L. Conley's net worth?: The estimated net worth of Sheryl L. Conley is at least $35,109.72 as of June 1st, 2021. Ms. Conley owns 39,672 shares of Neuronetics stock worth more than $35,110 as of November 23rd. This net worth approximation does not reflect any other assets that Ms. Conley may own. Learn More about Sheryl L. Conley's net worth.
How do I contact Sheryl L. Conley?: The corporate mailing address for Ms. Conley and other Neuronetics executives is 3222 PHOENIXVILLE PIKE, MALVERN PA, 19355. Neuronetics can also be reached via phone at (610) 640-4202 and via email at [email protected]. Learn More on Sheryl L. Conley's contact information.
Has Sheryl L. Conley been buying or selling shares of Neuronetics?: Sheryl L. Conley has not been actively trading shares of Neuronetics over the course of the past ninety days. Most recently, Sheryl L. Conley sold 6,200 shares of the business's stock in a transaction on Tuesday, June 1st. The shares were sold at an average price of $14.03, for a transaction totalling $86,986.00. Following the completion of the sale, the director now directly owns 39,672 shares of the company's stock, valued at $556,598.16. Learn More on Sheryl L. Conley's trading history.
Who are Neuronetics' active insiders?: Neuronetics' insider roster includes Robert Cascella (Director), Sheryl Conley (Director), Stephen Furlong (CFO), Gregory Harper (VP), William Macan (VP), Bruce Shook (Director), and Keith Sullivan (CEO). Learn More on Neuronetics' active insiders.
Are insiders buying or selling shares of Neuronetics?: In the last twelve months, Neuronetics insiders bought shares 7 times. They purchased a total of 261,776 shares worth more than $277,669.60. In the last twelve months, insiders at the sold shares 16 times. They sold a total of 222,765 shares worth more than $646,181.07. The most recent insider tranaction occured on October, 8th when CFO Stephen Furlong sold 1,368 shares worth more than $1,121.76. Insiders at Neuronetics own 9.8% of the company. Learn More about insider trades at Neuronetics.
Information on this page was last updated on 10/8/2024.

Sheryl L. Conley Insider Trading History at Neuronetics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/1/2021	Sell	6,200	$14.03	$86,986.00	39,672

Sheryl L. Conley Buying and Selling Activity at Neuronetics

Neuronetics Company Overview

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Today's Range

Now: $0.89

$0.84

$0.93

50 Day Range

MA: $0.90

$0.61

$1.19

2 Week Range

Now: $0.89

$0.52

$5.07

Volume

292,263 shs

Average Volume

819,022 shs

Market Capitalization

$26.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.21

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.